BIOMARIN PHARMACEUTICAL INC (BMRN) insider trading

By person

19 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Alexander Hardy

Chief Executive Officer

—

214,635

$14.23M

+44.6%

Richard A Meier

Director

—

127,426

$8.45M

+5.5%

Brian Mueller

EVP, Chief Financial Officer

—

123,314

$8.17M

+71.4%

Charles Greg Guyer

EVP, Chief Technical Officer

—

84,140

$5.58M

+12.8%

George Eric Davis

EVP, Chief Legal Officer

—

61,003

$4.04M

+7.9%

Robert J. Hombach

Director

—

49,360

$3.27M

+40.1%

Gregory R Friberg

EVP, Chief R&D Officer

—

47,732

$3.16M

+62.0%

Willard H Dere

Director

—

46,440

$3.08M

+43.8%

Cristin Hubbard

EVP, Chief Commercial Officer

—

42,472

$2.82M

+118.1%

Elizabeth M Anderson

Director

—

41,940

$2.78M

+50.9%

Maykin Ho

Director

—

35,500

$2.35M

+66.2%

Rashmi Virendra Ramchandani

VP, Chief Accounting Officer

—

25,610

$1.70M

—

Barbara W. Bodem

Director

—

21,045

$1.39M

+204.8%

Mark J Enyedy

Director

—

21,040

$1.39M

+204.9%

Athena Countouriotis

Director

—

21,040

$1.39M

+204.9%

Timothy P Walbert

Director

—

17,270

$1.14M

—

Ian T Clark

Director

—

14,490

$960.46K

—

Erin Burkhart

GVP, Chief Accounting Officer

—

14,173

$939.44K

−1.9%

Robert M Plenge

Director

—

6,140

$406.98K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

BIOMARIN PHARMACEUTICAL INC

What the insiders did No buying or selling

By person